Crowley John F 的 Form 4 申報
Intellia Therapeutics, Inc.（NTLA），2021/10/7 申報
- 申報編號
- 0001209191-21-059960
- 申報時間
- 2021/10/7
- 交易日
- 2021/10/5
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $130.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Crowley John FCIK 0001400973 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/5 | Common Stock | M行使選擇權取得 | +10,000 | $18.83 | +$188,300 | 12,094 | 直接 | |
| 2021/10/5 | Common Stock | S賣出處分 | −1,280 | $128.83F2 | −$164,902.4 | 10,814 | 直接 | |
| 2021/10/5 | Common Stock | S賣出處分 | −2,915 | $129.88F3 | −$378,600.2 | 7,899 | 直接 | |
| 2021/10/5 | Common Stock | S賣出處分 | −3,759 | $130.92F4 | −$492,128.28 | 4,140 | 直接 | |
| 2021/10/5 | Common Stock | S賣出處分 | −1,846 | $131.74F5 | −$243,192.04 | 2,294 | 直接 | |
| 2021/10/5 | Common Stock | S賣出處分 | −200 | $132.84 | −$26,568 | 2,094 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/5 | Common Stock | M行使選擇權處分 | −10,000 | $0.00 | $0 | 28,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.09 to $129.05, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.28 to $130.25, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.445 to $131.42, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.445 to $132.24, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。